SlideShare a Scribd company logo
1 of 22
ALZHEIMER’S DISEASE
Clerkship
Arjan Aryal
5th year Pharm. D
DEMOGRAPHIC DATA
NAME X
Age 76
Sex Male
IP No. 384952
Department Psychiatric
Ward Male Psychiatric Ward
Unit I
Weight 98 kg
Height 5’11’’ cm
BMI 30.13
DOA 14/12/2015
DOD 30/12/2015
LOS 16 days.
SUBJECTIVE DATA
PATIENT COMPLAINTS
 Memory loss and blackouts (during driving).
 Increased forgetfulness , insidious in onset , slowly
progressive ( forgets appointments, phone calls).
 Problems in walking ( uses cane to walk around
house).
 Confused and easily becomes lost.
 Difficulty in sleeping.
 Aggression shown few times.
SOCIAL HISTORY
Smoker: Yes (45 Years)
Alcoholic: No , occasional.
Occupation: Company Owner, looked after by his
son currently.
Diet: High Protein diet , mostly non vegetarian.
Education: MBA
Marital status: Married
Allergy: No Known allergies
NO FAMILY HISTORY
PAST MEDICAL HISTORY:
H/O Asthma (15 Years)
No h/o head injury, strokes.
PAST MEDICATION HISTORY :
Neb Duolin+Budecort (20/100 mcg+ 200 mcg) (1-1-1)
Tab Theophylline 400 mg/day (1/2-0-1/2)
PHYSICAL EXAMINATION
 Patient was confused and not oriented to time.
 Aphasia
 Apraxia
 CNS: NAD
 P/A: Soft, Non tender.
 RS: NVBS
 CVS: S1S2 positive
 PMA: decreased.
 Mood: Anxious, Depressed.
OBJECTIVE DATA
VITALS 14-16 17-20 21-25 26-29 30
BP 170/110
mmHg
160/110
mmHg
160/100
mmHg
150/90mmHg 140/80
mmHg
RR 19 b/m 20 b/m 22 b/m 20 b/m 20 b/m
Pulse 95 b/m 92 b/m 97 b/m 90 b/m 90 b/m
Temp 98.6°F 98.6°F 98.6°F 98.6°F 98.6°F
LAB INVESTIGATIONS
TEST Normal 14 22
Blood Sugar
Fasting 70-110 mg/dl 120 82
Post Prandial 110-140 mg/dl 145 113
Hematology
Hb% 12-18 g/dl 14.2 16
PCV 32-47% 38% -
WBC Count 5000-11000
cells/cumm
6500 8000
Neutrophils 40-75% 66 65
Lymphocytes 20-50% 33 41
Platelets 1.5-4.5 lakh/cumm 1.6 2.3
ESR 0-20 mm/hr 22 17
LAB INVESTIGATIONS
TEST Normal 14 22
Urea and
Creatinine
Serum Urea 20-50 mg/dl 52 50
Serum Creatinine 0.9-1.1 mg/dl 1.1 1.1
Electrolytes
Sodium 136-145 mEq/L 136 139
Potassium 3.5-4.5 mEq/L 4.2 4.0
LAB INVESTIGATIONS
LIPID
PROFILE
TEST
Normal 14 22
Triglycerides Upto 150
mg/dl
200 160
Total
Cholesterol
Upto 200
mg/dl
421 336
HDL
Cholesterol
30-60 mg/dl 48 52
LDL
Cholesterol
Upto 100
mg/dl
191 156
VLDL
Cholesterol
Upto 20 mg/dl 30 20
Urine analysis
Urine Analysis 16
Volume 10 ml
Colour Pale Yellow
Turbidity Clear
Albumin +2
Sugar Nil
Pus Cells 2-3
Ep Cells 1-2
Liver Function Test
LFT Normal Range Result (14)
Total Bilirubin 0.3-1.2 mg/dl 0.8
Direct Bilirubin 0-0.2 mg/dl 0.3
Indirect Bilirubin 0.3-1 mg/dl 0.5
SGOT Upto 35 IU/L 32
SGPT Upto 45 IU/L 13
ALP 53-128 IU/L 78
Protein Analysis
Total Protein 6.4-8.3 mg/dl 8.2
Albumin 3.5-5.2 mg/dl 5.5
Diagnostic Tests.
 CBC: ruled out potential causes of memory loss
and confusion such as thyroid disorder or vitamin
deficiencies. (14th, 22nd )
 MRI showed no shrinkage of brain, ruled out
Multi infarct vascular dementia. (14th)
 Renal Function test done that reported GFR of
92 ml/min which ruled out renal impairment.(16th)
 Lipid Profile test showed hyperlipidaemia. (14th,
22nd)
 MMSE score of 16 resulting in Moderate
Alzheimer’s Disease. (14th) .
Diagnosis
ALZHEIMER’S
DISEASE
TREATMENT GOALS
 To maintain functioning of brain as long as possible.
 To treat psychiatric and behavioral symptoms.
DRUGS PRESCRIBED
TRADE NAME GENERIC NAME DOSE FREQ. 14 15 16 17 18
-
30
Tb Aricept Donepezil 5 mg 0-0-1 √ √ √ √ √
Neb Duolin
+Budecort
Ipratropium
Bromide+Levosalbutamol+
Budesonide
20/50 mcg+
200 mcg
(60/150+600
mcg)
1-1-1 √ √ √ √ √
Tb Aten Atenolol 50 mg 1-0-0 √ √ √ √ √
Risperdal Risperidone 0.5 mg
(1 mg)
1-0-1 √ √ √ √ √
Tb Atorva Atorvastatin 40 mg 0-0-1 √ √ √ √ √
Tb Pan Pantoprazole 40 mg 1-0-0 √ √ √ √ √
Tb Sartine Sertraline 50 mg 0-0-1 √ √ √ √ √
Discharge Medication.
Medication Dose Frequency QTY/Duration
Tb Aricept 5 mg 0-0-1 3 months
Neb Duolin
+Budecort
20/50 mcg+ 200 mcg 1-1-1 Further orders
Tb Aten 50 mg 1-0-0 Further orders
Risperdal 0.5 mg 1-0-1 3 months
Tb Atorva 20 mg 0-0-1 Further orders
Tb Pan 40 mg 1-0-0 Continue
Tb Sartine 25 mg 0-0-1 3 months
FOLLOW UP – 3 Months
CARE TAKER EDUCATION
 Educate about the disease to the patient’s care
taker such as environmental modification, task
simplification for the patient.
 Discuss in detail about the diagnosis, progression
and treatment choices.
 Discuss about basic legal and financial planning
with the care taker related to the disease.
 Give constant care to the patient.
 Referral to social service agencies or support
organization incase of uncontrollable progression
of disease.
PATIENT EDUCATION
 Adhere to medication.
 Avoid Stress.
 Quit Smoking.
 Take diet such as fish, food rich in antioxidants
(berries), green vegetables like spinach, cabbage,
food rich in Vit E, Vit D avoid salty and fried foods.
 Engage yourself in some works, go for walks (with
caregiver).
 Check your blood sugar level frequently . (
risperidone, Atorvastatin).
 Do ECG to check if any irregular heart beat rhythm
persists. (sertraline + risperidone).
Patient Counselling
O Do not do strenuous exercise like running or
lifting weights as it can worsen your condition.
O Avoid animal furs as it acts as a source for
spreading allergen.
O Go for vacations, and relax.
O Do not take grape fruit juice along with
atorvastatin.
O Adhere to same medication ( in case of signs
of improvement).
References.
O http://shp.missouri.edu/vhct/case1299/references.htm
O http://shp.missouri.edu/vhct/case2400/behavior.htm
O http://www.alz.org/alzheimers_disease_steps_to_diagnosis.asp#brain
O http://www.alz.org/socal/images/professional_natlguideline.pdf
O http://www.medscape.org/viewarticle/420328
O https://www.nice.org.uk/guidance/ta217/chapter/4-Evidence-and-
interpretation
O https://www.nia.nih.gov/alzheimers/publication/alzheimers-disease-
medications-fact-sheet
O http://www.aafp.org/afp/2011/0615/p1403.html
O http://www.alzheimer-europe.org/Dementia/Alzheimer-s-disease/How-
is-Alzheimer-s-disease-diagnosed#fragment3
O http://www.mayoclinic.org/diseases-conditions/alzheimers-
disease/diagnosis-treatment/diagnosis/dxc-20167109
O http://www.medicaldaily.com/smoking-cocaine-and-3-other-ways-you-
can-kill-your-brain-cells-325920
O Joseph T.DiPiro, Pharmacotherapy handbook.
O Drugs.com
Alzheimers

More Related Content

What's hot

What's hot (7)

Poorly controlled diabetes and eating disorders
Poorly controlled diabetes and eating disordersPoorly controlled diabetes and eating disorders
Poorly controlled diabetes and eating disorders
 
Natural Treatment of Diabetes | Planet Ayurveda
Natural Treatment of Diabetes | Planet AyurvedaNatural Treatment of Diabetes | Planet Ayurveda
Natural Treatment of Diabetes | Planet Ayurveda
 
Noura wl
Noura wlNoura wl
Noura wl
 
Irritable Bowel Syndrome (IBS)
Irritable Bowel Syndrome (IBS)Irritable Bowel Syndrome (IBS)
Irritable Bowel Syndrome (IBS)
 
Paliperidone ER Tablets Taj Pharma SmPC
Paliperidone ER Tablets Taj Pharma SmPCPaliperidone ER Tablets Taj Pharma SmPC
Paliperidone ER Tablets Taj Pharma SmPC
 
Dairy myth: The estrogen nightmare
Dairy myth: The estrogen nightmareDairy myth: The estrogen nightmare
Dairy myth: The estrogen nightmare
 
Management of diabetes
Management of diabetesManagement of diabetes
Management of diabetes
 

Similar to Alzheimers

Danielle.Degroot.Case Study Pp
Danielle.Degroot.Case Study PpDanielle.Degroot.Case Study Pp
Danielle.Degroot.Case Study Pp
DanielleDDI
 
Understand your blood test report
Understand your blood test reportUnderstand your blood test report
Understand your blood test report
Mb Narayanan
 

Similar to Alzheimers (20)

A Comparison of an Oral GLP-1 Receptor Antagonist and SGLT2 Inhibitor
A Comparison of an Oral GLP-1 Receptor Antagonist and SGLT2 InhibitorA Comparison of an Oral GLP-1 Receptor Antagonist and SGLT2 Inhibitor
A Comparison of an Oral GLP-1 Receptor Antagonist and SGLT2 Inhibitor
 
13. a case study on convulsions in a kco epilepsy with lactational amenorrhoea
13. a case study on convulsions in a kco epilepsy with lactational amenorrhoea13. a case study on convulsions in a kco epilepsy with lactational amenorrhoea
13. a case study on convulsions in a kco epilepsy with lactational amenorrhoea
 
notes_johnson_multimodal_approaches_to_hormones.pptx
notes_johnson_multimodal_approaches_to_hormones.pptxnotes_johnson_multimodal_approaches_to_hormones.pptx
notes_johnson_multimodal_approaches_to_hormones.pptx
 
8. a case study on typhoid fever
8. a case study on typhoid fever8. a case study on typhoid fever
8. a case study on typhoid fever
 
Lab intrepretation 2015
Lab intrepretation 2015 Lab intrepretation 2015
Lab intrepretation 2015
 
SAI DEEPAK CASE STUDY ON CHRONIC KIDNEY DISEASE
SAI DEEPAK CASE STUDY ON CHRONIC KIDNEY DISEASESAI DEEPAK CASE STUDY ON CHRONIC KIDNEY DISEASE
SAI DEEPAK CASE STUDY ON CHRONIC KIDNEY DISEASE
 
Biohacking Masterclass Slides Yohan Tengra.pdf
Biohacking Masterclass Slides Yohan Tengra.pdfBiohacking Masterclass Slides Yohan Tengra.pdf
Biohacking Masterclass Slides Yohan Tengra.pdf
 
Functions of primary health center in ncd care
Functions of primary health center in ncd careFunctions of primary health center in ncd care
Functions of primary health center in ncd care
 
Seminar nada pdf.pdf
Seminar nada pdf.pdfSeminar nada pdf.pdf
Seminar nada pdf.pdf
 
FARM ANALYSIS - PHARM.D.pptx
 FARM ANALYSIS - PHARM.D.pptx FARM ANALYSIS - PHARM.D.pptx
FARM ANALYSIS - PHARM.D.pptx
 
Case presentation on hypothyroidism
Case presentation on hypothyroidismCase presentation on hypothyroidism
Case presentation on hypothyroidism
 
Blood Pressure
Blood PressureBlood Pressure
Blood Pressure
 
sle depression case
sle depression casesle depression case
sle depression case
 
15. a case study on enteric fever
15. a case study on enteric fever15. a case study on enteric fever
15. a case study on enteric fever
 
An approach to mulitmorbidity in frail older adults
An approach to mulitmorbidity in frail older adultsAn approach to mulitmorbidity in frail older adults
An approach to mulitmorbidity in frail older adults
 
Mx of TB.pptx
Mx of TB.pptxMx of TB.pptx
Mx of TB.pptx
 
Danielle.Degroot.Case Study Pp
Danielle.Degroot.Case Study PpDanielle.Degroot.Case Study Pp
Danielle.Degroot.Case Study Pp
 
Understand your blood test report
Understand your blood test reportUnderstand your blood test report
Understand your blood test report
 
NPCDCS BY DR.R.MOHAN
NPCDCS  BY  DR.R.MOHANNPCDCS  BY  DR.R.MOHAN
NPCDCS BY DR.R.MOHAN
 
Mh session
Mh sessionMh session
Mh session
 

Alzheimers

  • 2. DEMOGRAPHIC DATA NAME X Age 76 Sex Male IP No. 384952 Department Psychiatric Ward Male Psychiatric Ward Unit I Weight 98 kg Height 5’11’’ cm BMI 30.13 DOA 14/12/2015 DOD 30/12/2015 LOS 16 days.
  • 3. SUBJECTIVE DATA PATIENT COMPLAINTS  Memory loss and blackouts (during driving).  Increased forgetfulness , insidious in onset , slowly progressive ( forgets appointments, phone calls).  Problems in walking ( uses cane to walk around house).  Confused and easily becomes lost.  Difficulty in sleeping.  Aggression shown few times.
  • 4. SOCIAL HISTORY Smoker: Yes (45 Years) Alcoholic: No , occasional. Occupation: Company Owner, looked after by his son currently. Diet: High Protein diet , mostly non vegetarian. Education: MBA Marital status: Married Allergy: No Known allergies NO FAMILY HISTORY
  • 5. PAST MEDICAL HISTORY: H/O Asthma (15 Years) No h/o head injury, strokes. PAST MEDICATION HISTORY : Neb Duolin+Budecort (20/100 mcg+ 200 mcg) (1-1-1) Tab Theophylline 400 mg/day (1/2-0-1/2)
  • 6. PHYSICAL EXAMINATION  Patient was confused and not oriented to time.  Aphasia  Apraxia  CNS: NAD  P/A: Soft, Non tender.  RS: NVBS  CVS: S1S2 positive  PMA: decreased.  Mood: Anxious, Depressed.
  • 7. OBJECTIVE DATA VITALS 14-16 17-20 21-25 26-29 30 BP 170/110 mmHg 160/110 mmHg 160/100 mmHg 150/90mmHg 140/80 mmHg RR 19 b/m 20 b/m 22 b/m 20 b/m 20 b/m Pulse 95 b/m 92 b/m 97 b/m 90 b/m 90 b/m Temp 98.6°F 98.6°F 98.6°F 98.6°F 98.6°F
  • 8. LAB INVESTIGATIONS TEST Normal 14 22 Blood Sugar Fasting 70-110 mg/dl 120 82 Post Prandial 110-140 mg/dl 145 113 Hematology Hb% 12-18 g/dl 14.2 16 PCV 32-47% 38% - WBC Count 5000-11000 cells/cumm 6500 8000 Neutrophils 40-75% 66 65 Lymphocytes 20-50% 33 41 Platelets 1.5-4.5 lakh/cumm 1.6 2.3 ESR 0-20 mm/hr 22 17
  • 9. LAB INVESTIGATIONS TEST Normal 14 22 Urea and Creatinine Serum Urea 20-50 mg/dl 52 50 Serum Creatinine 0.9-1.1 mg/dl 1.1 1.1 Electrolytes Sodium 136-145 mEq/L 136 139 Potassium 3.5-4.5 mEq/L 4.2 4.0
  • 10. LAB INVESTIGATIONS LIPID PROFILE TEST Normal 14 22 Triglycerides Upto 150 mg/dl 200 160 Total Cholesterol Upto 200 mg/dl 421 336 HDL Cholesterol 30-60 mg/dl 48 52 LDL Cholesterol Upto 100 mg/dl 191 156 VLDL Cholesterol Upto 20 mg/dl 30 20
  • 11. Urine analysis Urine Analysis 16 Volume 10 ml Colour Pale Yellow Turbidity Clear Albumin +2 Sugar Nil Pus Cells 2-3 Ep Cells 1-2
  • 12. Liver Function Test LFT Normal Range Result (14) Total Bilirubin 0.3-1.2 mg/dl 0.8 Direct Bilirubin 0-0.2 mg/dl 0.3 Indirect Bilirubin 0.3-1 mg/dl 0.5 SGOT Upto 35 IU/L 32 SGPT Upto 45 IU/L 13 ALP 53-128 IU/L 78 Protein Analysis Total Protein 6.4-8.3 mg/dl 8.2 Albumin 3.5-5.2 mg/dl 5.5
  • 13. Diagnostic Tests.  CBC: ruled out potential causes of memory loss and confusion such as thyroid disorder or vitamin deficiencies. (14th, 22nd )  MRI showed no shrinkage of brain, ruled out Multi infarct vascular dementia. (14th)  Renal Function test done that reported GFR of 92 ml/min which ruled out renal impairment.(16th)  Lipid Profile test showed hyperlipidaemia. (14th, 22nd)  MMSE score of 16 resulting in Moderate Alzheimer’s Disease. (14th) .
  • 15. TREATMENT GOALS  To maintain functioning of brain as long as possible.  To treat psychiatric and behavioral symptoms.
  • 16. DRUGS PRESCRIBED TRADE NAME GENERIC NAME DOSE FREQ. 14 15 16 17 18 - 30 Tb Aricept Donepezil 5 mg 0-0-1 √ √ √ √ √ Neb Duolin +Budecort Ipratropium Bromide+Levosalbutamol+ Budesonide 20/50 mcg+ 200 mcg (60/150+600 mcg) 1-1-1 √ √ √ √ √ Tb Aten Atenolol 50 mg 1-0-0 √ √ √ √ √ Risperdal Risperidone 0.5 mg (1 mg) 1-0-1 √ √ √ √ √ Tb Atorva Atorvastatin 40 mg 0-0-1 √ √ √ √ √ Tb Pan Pantoprazole 40 mg 1-0-0 √ √ √ √ √ Tb Sartine Sertraline 50 mg 0-0-1 √ √ √ √ √
  • 17. Discharge Medication. Medication Dose Frequency QTY/Duration Tb Aricept 5 mg 0-0-1 3 months Neb Duolin +Budecort 20/50 mcg+ 200 mcg 1-1-1 Further orders Tb Aten 50 mg 1-0-0 Further orders Risperdal 0.5 mg 1-0-1 3 months Tb Atorva 20 mg 0-0-1 Further orders Tb Pan 40 mg 1-0-0 Continue Tb Sartine 25 mg 0-0-1 3 months FOLLOW UP – 3 Months
  • 18. CARE TAKER EDUCATION  Educate about the disease to the patient’s care taker such as environmental modification, task simplification for the patient.  Discuss in detail about the diagnosis, progression and treatment choices.  Discuss about basic legal and financial planning with the care taker related to the disease.  Give constant care to the patient.  Referral to social service agencies or support organization incase of uncontrollable progression of disease.
  • 19. PATIENT EDUCATION  Adhere to medication.  Avoid Stress.  Quit Smoking.  Take diet such as fish, food rich in antioxidants (berries), green vegetables like spinach, cabbage, food rich in Vit E, Vit D avoid salty and fried foods.  Engage yourself in some works, go for walks (with caregiver).  Check your blood sugar level frequently . ( risperidone, Atorvastatin).  Do ECG to check if any irregular heart beat rhythm persists. (sertraline + risperidone).
  • 20. Patient Counselling O Do not do strenuous exercise like running or lifting weights as it can worsen your condition. O Avoid animal furs as it acts as a source for spreading allergen. O Go for vacations, and relax. O Do not take grape fruit juice along with atorvastatin. O Adhere to same medication ( in case of signs of improvement).
  • 21. References. O http://shp.missouri.edu/vhct/case1299/references.htm O http://shp.missouri.edu/vhct/case2400/behavior.htm O http://www.alz.org/alzheimers_disease_steps_to_diagnosis.asp#brain O http://www.alz.org/socal/images/professional_natlguideline.pdf O http://www.medscape.org/viewarticle/420328 O https://www.nice.org.uk/guidance/ta217/chapter/4-Evidence-and- interpretation O https://www.nia.nih.gov/alzheimers/publication/alzheimers-disease- medications-fact-sheet O http://www.aafp.org/afp/2011/0615/p1403.html O http://www.alzheimer-europe.org/Dementia/Alzheimer-s-disease/How- is-Alzheimer-s-disease-diagnosed#fragment3 O http://www.mayoclinic.org/diseases-conditions/alzheimers- disease/diagnosis-treatment/diagnosis/dxc-20167109 O http://www.medicaldaily.com/smoking-cocaine-and-3-other-ways-you- can-kill-your-brain-cells-325920 O Joseph T.DiPiro, Pharmacotherapy handbook. O Drugs.com